RinGlar 300 GF

    RinGlar 300 GF — package

    info General information

    Name RinGlar 300 GF, 300 U/mL, 1.5 mL, solution for injection
    INN Insulin glargine
    Active substance Insulin glargine
    Pharmacotherapeutic group Drugs used in diabetes. Insulins and analogues. Long-acting insulins and analogues for injection. Insulin glargine.
    Dosage form Solution for injection.
    Packaging

    1.5 mL of the product in colorless glass cartridges.

    1. 5 cartridges in a blister pack. 1 blister pack is placed in a cardboard box.

    2. The cartridge is installed in a plastic multi-dose disposable pen injector for repeated injections, Geropharm Pen. 3 or 5 pre-filled multi-dose disposable pen injectors for repeated injections, Geropharm Pen, are placed in a cardboard box.

    Manufacturer Karaganda Pharmaceutical Complex LLP EU GMP

    assignment_turned_in Indications

    RinGlar 300 GF is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 6 years and older.